Cunninghamella elegans

Cun·ning·ham·el·la el·e·gans

(kŭn'ing-ha-mel'ă el'ĕ-ganz),
One of several species of fungi that can cause mucormycosis in humans.
References in periodicals archive ?
Biotransformation of chlorpromazine and methdilazine by Cunninghamella elegans. Appl.
Se han reportado reacciones oxidativas sobre el DBT por cepas de Pseudomonas (Huertas et al.; 1998; McFarland et al., 1998; Izumi et al., 1994; Laborde y Gibson, 1977), Corynebacterium (Omori et al., 1992), Arthrobacter (Konishi et al., 1986), Beijerinkia (Laborde y Gibson, 1977), Rhodococcus (Fedorak y Westlake, 1983; Laborde y Gibson, 1977; Monticello y Finnerty, 1985), Desulfovibrio (Armstrons et al., 1995), Rhizobium meliloti (Frassinetti et al., 1998) y Cunninghamella elegans (Crawford y Gupta, 1990).
Crawford y Gupta (1990) reportaron la remocion del 97,3% del azufre presente en 90 ppm de DBT iniciales, mediante el uso de Cunninghamella elegans en un lapso de 24 horas; similarmente, Omori et al.
The technology grew out of the use of microorganisms in organic synthesis, "In the process of doing that, we discovered that a select group of fungi have the ability to metabolize a wide variety of drugs in much the same way people do." The fungus that has shown most promise is Cunninghamella elegans, which has proven itself to be one of the best in metabolizing drugs the way mammals do.